跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 124 条关于
“DiogenX”
全部
124
临床试验
9
药物
25
机构
25
资讯
65
去年
Zucara Therapeutics Secures $25M Series B Funding to Advance First-in-Class Hypoglycemia Prevention Therapy
去年
Biogen Withdraws Aduhelm EU Application Following Regulatory Setback
去年
Eisai and Biogen Pursue Subcutaneous Leqembi Approval for Alzheimer's
2年前
Biogen Expands into Immunology with Acquisition of HI-Bio
3个月前
BioGene Therapeutics Appoints Ty Howton, Veteran Biopharma Executive, to Board of Directors
去年
Biogen Advances LEQEMBI Treatment with Subcutaneous Formulation for Alzheimer's Disease
去年
Eisai and Biogen Launch Alzheimer's Drug Leqembi in South Korea
去年
Biogen Executives Address Investor Pressure and Strategic Focus at JPM25
去年
Biogen's Felzartamab Receives FDA Breakthrough Therapy Designation for Kidney Transplant Rejection
去年
Eisai and Biogen Seek Approval for Leqembi Autoinjector, Aiming for 2025 Launch
第 1 页,共 7 页
上一页
下一页